Humans& launches Ampersand v0.1, a model trained to help groups pursue shared goals over time
It is available now through an OpenAI-compatible agents API with no waitlist; benchmark claims come from the company.
Meta details Prometheus, its gigawatt-scale Ohio AI cluster, and plans to reach one million GPUs
Meta says the first phase is complete and trained its Muse models, using hundreds of thousands of GPUs across connected buildings.
Bob McGrew's Arda raises $160 million at $1.5 billion to speed up U.S. factory lines with AI
Altimeter, Accel and Khosla co-led the Series A; the software turns product designs into assembly instructions, with Anduril as design partner.
Tenstorrent raises $1.5 billion at a $6.2 billion valuation to scale Galaxy AI servers
Trace Capital and Innovation X led the Series E; funds also go to RISC-V CPU and AI IP licensing.
NVIDIA simulates a 104-qubit magic state protocol with realistic noise on Europe's JUPITER supercomputer
The run used 8,192 GH200 GPUs and 512 TiB of memory; it validates one cultivation protocol, not a full 104-qubit processor.
China proposes export controls on 23 AI technologies, including frontier model weights and agents
StepFun releases Step 5 Preview open weights, a 600B multimodal MoE model
Monkey recordings show the brain switching between seen and suppressed images about 15 times a second
FDA approves Viatris's Ryzumvi eye drops for presbyopia in adults
Bristol Myers says actinium-225 therapy RYZ101 meets Phase 3 progression-free survival goal
Taiwan plans to make unauthorized AI chip and server exports to China a crime, reports say
SpaceXSI releases Grok Voice 3.0, which tops Artificial Analysis's speech-to-speech index
OpenAI acquires Orchestra Bio to bring drug-development tracking into its Rosalind suite
Orchestra's agents monitor studies and timelines while humans keep decisions; terms, pricing and release dates were not disclosed.
NVIDIA and UW's Institute for Protein Design release RFD4-Proteina as an open protein design model
The BSD-licensed model jointly designs sequence and all-atom structure across seven tasks, including binders, enzymes and antibodies.
FDA grants accelerated approval to dostarlimab for dMMR locally advanced rectal cancer
In the 154-patient AZUR-1 study, 71% were treated with dostarlimab alone without further therapy or progression.
Anthropic commits 5% of its shares to a new Public Benefit Fund, pending shareholder approval
The board may add 2% for each 50% rise in value above a baseline; the fund's equity cannot be used for lobbying or political giving.
Elorian releases Glimpse, a visual reasoning model that re-inspects images while it thinks
Anthropic gives METR staff employee-level access and lets it publish risk assessments without veto
IonQ and the University of Cambridge open a quantum innovation centre at the Cavendish Laboratory
FDA approves self-administered autoinjector for UCB's myasthenia gravis drug Zilbrysq
Arrowhead's RNAi drug ARO-MAPT cuts spinal-fluid tau by up to 73% in healthy volunteers
NEURA Robotics introduces Neuron AI, a robot foundation model that combines vision, touch, sound and memory
Anthropic tells investors Q3 revenue reached $16.8 billion, up 45% from Q2, reports say
Rapport's RAP-219 meets Phase 2 endpoints in acute bipolar mania
YMRS scores improved 3.1 points more than placebo at week 3 in 253 inpatients (p=0.045); Phase 3 is planned for late 2027.
Quantinuum reports 99.9995% logical fidelity on Helios, a tenfold error-correction improvement
A distance-7 color code on trapped ions cut errors about 12-fold per distance step; the result covers one logical qubit in memory.
Disc Medicine's bitopertin meets all endpoints in Phase 3 APOLLO for erythropoietic protoporphyria
Protoporphyrin IX fell 41.4% versus placebo and pain-free light time rose 12.2 hours; Disc plans to resubmit to the FDA by end-2026.